Enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic myogenous facial pain

European Journal of Pain

Volumn 13, Issue 6, 2009, Pages 600-605

  Galli, Ursula ^a   Gaab, Jens ^a   Ettlin, Dominik A ^a   Ruggia, Fidel ^a   Ehlert, Ulrike ^a   Palla, Sandro ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chronic myogenous facial pain; Hypothalamus pituitary adrenal axis; Low dose dexamethasone suppression test; Salivary cortisol

Indexed keywords

HYDROCORTISONE;

ADULT; AROUSAL; ARTICLE; CHRONIC PAIN; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FACE PAIN; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MASTICATORY MUSCLE; NEGATIVE FEEDBACK; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOMETRY; SLEEP;

ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; AREA UNDER CURVE; CHRONIC DISEASE; DEPRESSION; DEXAMETHASONE; FATIGUE; FEEDBACK; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MENTAL FATIGUE; MYOFASCIAL PAIN SYNDROMES; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SALIVA; SLEEP;

EID: 67349165400     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.07.010     Document Type: Article

References (48)

1. Aaron L.A., and Buchwald D. Fibromyalgia and other unexplained clinical conditions. Curr Rheumatol Rep 3 (2001) 116-122
2. Aghabeigi B., Feinmann C., and Harris M. Prevalence of post-traumatic stress disorder in patients with chronic idiopathic facial pain. Br J Oral Maxillofac Surg 30 (1992) 360-364
3. Barsky A., and Borus J. Functional somatic syndromes. Ann Intern Med 130 (1999) 910-921
4. Bohmelt A.H., Nater U., Franke S., Hellhammer D., and Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 67 (2005) 288-294
5. Broderick J.E., Arnold D., Kudielka B.M., and Kirschbaum C. Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29 (2004) 636-650
6. Buchner A, Faul F, Erdfelder E. G Power: a priori, post-hoc, and compromise power analyses for the Macintosh (version 2.1.2); 1997.
7. Cassidy F., Ritchie J., Verghese K., and Carroll B. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors. Biol Psychiatry 47 (2000) 677-680
8. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., and Wright D. Development of a fatigue scale. J Psychosom Res 37 (1993) 147-153
9. De Kloet E.R. Why dexamethasone poorly penetrates in brain. Stress 2 (1997) 13-20
10. Dworkin S., and Leresche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6 (1992) 301-355
11. Dworkin S.F., and Massoth D.L. Temporomandibular disorders and chronic pain: disease or illness?. J Prosthet Dent 72 (1994) 29-38
12. Ehlert U., Nater U., and Bohmelt A. High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res 59 (2005) 7-10
13. Gaab J., Huster D., Peisen R., Engert V., Schad T., and Schurmeyer T. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 64 (2002) 311-318
14. Gaab J., Baumann S., Budnoik A., Gmunder H., Hottinger N., and Ehlert U. Reduced reactivity and enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic whiplash-associated disorder. Pain 119 (2005) 219-224
15. Glaros A., Urban D., and Locke J. Headache and temporomandibular disorders: evidence for diagnostic and behavioural overlap. Cephalalgia 27 (2007) 542-549
16. Goenjian A., Yehuda R., Pynoos R.S., Steinberg A., Tashjian M., and Yang R. Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia. Am J Psychiatry 153 (1996) 929-934
17. Griep E., Boersma J.W., Lentjes E.G., Prins A., Van Der Korst J.K., and De Kloet E.R. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25 (1998) 1374-1381
18. Hargreaves K., Mueller G.P., Dubner R., Goldstein D., and Dionne R. Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Res 422 (1987) 154-157
19. Heim C., Ehlert U., Hanker J.P., and Hellhammer D. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 60 (1998) 309-318
20. Herman J., and Cullinan W. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20 (1997) 78-84
21. Hunt G., O'Sullivan B., Johnson G., and Caterson I. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls. Psychiatry Res 36 (1991) 209-222
22. Jerjes W., Madland G., Feinmann C., Hopper C., Kumar M., Upile T., et al. A psychological comparison of temporomandibular disorder and chronic daily headache: are there targets for therapeutic interventions?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 367-373
23. Jones D., Rollman G.B., and Brooke R.I. The cortisol response to psychological stress in temporomandibular dysfunction. Pain 72 (1997) 171-182
24. Korszun A., Papadopoulos E., Demitrack M., Engleberg C., and Crofford L. The relationship between temporomandibular disorders and stress-associated syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 (1998) 416-420
25. Korszun A., Young E., Singer K., Carlson N.E., Brown M., and Crofford L. Basal circadian cortisol secretion in women with temporomandibular disorders. J Dent Res 81 (2002) 279-283
26. Kudielka B.M., Broderick J.E., and Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom Med 65 (2003) 313-319
27. Kudielka B.M., Fischer J.E., Metzenthin P., Helfricht S., Preckel D., and von Känel R. No effect of 5-day treatment with acetylsalicylic acid (aspirin) or the beta-blocker propranolol (Inderal) on free cortisol responses to acute psychosocial stress: a randomized double-blind, placebo-controlled study. Neuropsychobiology 56 (2007) 159-166
28. Lariviere W., and Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 84 (2000) 1-12
29. Leblebici B., Pektas Z.O., Ortancil O., Hurcan E., Bagis S., and Akman M. Coexistence of fibromyalgia, temporomandibular disorder, and masticatory myofascial pain syndromes. Rheumatol Int 27 (2007) 541-544
30. Levitan R.D., Vaccarino F., Brown G., and Kennedy S.H. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 27 (2002) 47-51
31. Macfarlane T., Blinkhorn A., Davies R., Ryan P., Worthington H., and Macfarlane G. Orofacial pain: just another chronic pain? Results from a population-based survey. Pain 99 (2002) 453-458
32. Meinlschmidt G., and Heim C. Decreased cortisol awakening response after early loss experience. Psychoneuroendocrinology 30 (2005) 568-576
33. Palla S. A need to redefine chronic pain?. J Orofac Pain 20 (2006) 265-266
34. Parker A.J., Wessely S., and Cleare A.J. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31 (2001) 1331-1345
35. Pruessner J., Wolf O., Hellhammer D., Buske-Kirschbaum A., Von Auer K., and Jobst S. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 61 (1997) 2539-2549
36. Sarlani E., and Greenspan J. Evidence for generalized hyperalgesia in temporomandibular disorders patients. Pain 102 (2003) 221-226
37. Stratmann U., Mokrys K., Meyer U., Kleinheinz J., Joos U., and Dirksen D. Clinical anatomy and palpability of the inferior lateral pterygoid muscle. J Prosthet Dent 83 (2000) 548-554
38. Suvinen T., Reade P., Kemppainen P., Kononen M., and Dworkin S. Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain 9 (2005) 613-633
39. Tanriverdi F., Karaca Z., Unluhizarci K., and Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10 (2007) 13-25
40. Turp J., and Minagi S. Palpation of the lateral pterygoid region in TMD - where is the evidence?. J Dent 29 (2001) 475-483
41. Von Korff M., Dworkin S.F., Le Resche L., and Kruger A. An epidemiologic comparison of pain complaints. Pain 32 (1988) 173-183
42. Wessely S., Nimnuan C., and Sharpe M. Functional somatic syndromes: one or many?. Lancet 354 (1999) 936-939
43. Wilhelm I., Wilhelm I., Born J., Kudielka B.M., Schlotz W., and Wüst S. Is the cortisol awakening rise a response to awakening?. Psychoneuroendocrinology 32 (2007) 358-366
44. Wingenfeld K., Wagner D., Schmidt I., Meinlschmidt G., Hellhammer D., and Heim C. The low-dose dexamethasone suppression test in fibromyalgia. J Psychosom Res 62 (2007) 85-91
45. Wittchen H., and Pfister H. DIA-X Interviews: Manual für Screening-Verfahren und Interview (1997), Swets & Zeltinger, Frankfurt
46. Yehuda R., Southwick S., Krystal J., Bremner D., Charney D., and Mason J. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 150 (1993) 83-86
47. Yoshihara T., Shigeta K., Hasegawa H., Ishitani N., Masumoto Y., and Yamasaki Y. Neuroendocrine responses to psychological stress in patients with myofascial pain. J Orofac Pain 19 (2005) 202-208
48. Zigmond A., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370